Arbutus Biopharma (ABUS)
(Delayed Data from NSDQ)
$2.58 USD
-0.02 (-0.77%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $2.59 +0.01 (0.39%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.10 | 0.00% |
Earnings Summary
For their last quarter, Arbutus Biopharma (ABUS) reported earnings of -$0.12 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ABUS's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for ABUS
Arbutus (ABUS) to Focus on Hepatitis B Candidates, Stock Up
ABUS: What are Zacks experts saying now?
Zacks Private Portfolio Services